Recombinant Human Anti-CD2 x Human Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) (BSCFV-H225)

Recombinant Anti-CD2 x Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD2 specificity or anti-TCR (Vβ8) specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can activate T cells. It is designed for the research of Tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CD2 & TCR (Vβ8)

Type

scFv-based Bispecific Fragments

Species Reactivity

Mouse

Application

FuncS; Promising therapeutic agent

Related Disease

Tumors

Targets

Target 1

CD2

Gene ID

12481

UniProt ID

P06729

Alternative Names

CD2; CD2 molecule; T11; SRBC; LFA-2; T-cell surface antigen CD2; leukocyte function-associated antigen-2; LFA-3 receptor; rosette receptor; erythrocyte receptor; lymphocyte-function antigen-2; T-cell surface antigen T11/Leu-5; CD2 antigen (p50), sheep red blood cell receptor

Target 2

TCR (Vβ8)

Gene ID

100124664

Alternative Names

Trbv8; T cell receptor beta variable 8; TCR; T-cell receptor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD2 x Human Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) (BSCFV-H225). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD2 x Human Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-H225)

Specifications

Targets

Customer Reviews and Q&As